Physician profile
Denise Wilson
NPI 1255370524
$5,905.19
in general payments reported to CMS, 2019-2025
39 companies · $1,950 in 2025
The $1,950 reported for 2025 was more than what 98% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $411 · 2022: $749 · 2023: $1,007 · 2024: $1,787 · 2025: $1,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,644 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,644.44 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,098.44 | 2022-2025 | |
| Lilly USA, LLC | $549.65 | 2021-2025 | Kisunla, Emgality, Reyvow |
| Pfizer INC. | $433.60 | 2021-2025 | |
| Biogen, INC. | $401.50 | 2022-2025 | Tysabri, Vumerity, Skyclarys |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $349.18 | 2021-2023 | Relistor |
| Alexion Pharmaceuticals, INC. | $343.39 | 2023-2025 | Ultomiris |
| Collegium Pharmaceutical, INC. | $325.79 | 2021-2025 | Belbuca, Xtampza |
| Lundbeck LLC | $288.11 | 2024-2025 | Vyepti |
| Eisai INC. | $260.37 | 2023-2025 | |
| Medtronic, INC. | $224.47 | 2023-2025 | Inceptiv, Intellis Adaptivestim, Vectris Surescan |
| Acadia Pharmaceuticals INC | $189.13 | 2024 | Nuplazid |
| Genentech USA, INC. | $141.42 | 2024-2025 | Ocrevus Zunovo, Ocrevus |
| Neurelis, INC. | $109.03 | 2024-2025 | Valtoco |
| Novartis Pharmaceuticals Corporation | $103.60 | 2024-2025 | |
| Celgene Corporation | $101.32 | 2024-2025 | Zeposia |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.